
RSV Vaccine and Monoclonal Antibody: Protecting Peri-Natal, Neo-Natal, and Infant Health
Speakers: Dr. Graeme N. Smith and Dr. Kirk Leifso
Program Highlights:
- Burden of Disease: Understanding the impact of RSV on pregnant individuals, neo-natal, and infants.
- RSV Vaccine: Latest developments and effectiveness.
- RSV Monoclonal Antibody: Innovations in protection.
- Provincial Rollout (Ontario) and Regional Plans: Implementation strategies.
- Q&A Session
Target Audience:
This webinar is designed for all healthcare providers in Ontario who work with pregnant individuals and newborns, including but not limited to:
- Pediatricians
- Obstetricians
- Family Physicians
- Nurse Practitioners
- Midwives
- Public Health Professionals
Learning Objectives:
1. Identify the burden of illness with RSV in the Pediatric population
2. Discuss the options for preventing severe RSV infection in newborns and infants
- Assess the suitability of the use of RSV vaccine in pregnancy for passive maternal antibody transfer to the fetus
- Assess the use of RSV monoclonal antibodies for newborns and infants
3. Discuss the national and provincial recommendations and plans for local roll-out
4. Collaborate with peers and fulfill their role in counselling patients/clients
Join us to enhance your knowledge of RSV and stay updated with the latest prevention strategies.
Credits
This Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by Queen’s University for up to 1 Mainpro+ credit. This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada and is approved by the Office of Continuing Professional Development, Queen’s University. You may claim a maximum of 1 hour.
View all our CPD Programs: Live, Online, and Complimentary on our "Get Your CPD" webpage.